(Q39641570)

13 September 2017

title

Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels (English)

1 reference

13 September 2017

Del-Río-Navarro BE

1

1 reference

13 September 2017

Luis Sienra-Monge JJ

2

1 reference

13 September 2017

Berber A

3

1 reference

13 September 2017

Torres-Alcántara S

4

1 reference

13 September 2017

Avila-Castañón L

5

1 reference

13 September 2017

Gómez-Barreto D

6

1 reference

13 September 2017

publication date

1 January 2003

1 reference

Allergologia et Immunopathologia

13 September 2017

published in

1 reference

13 September 2017

volume

31

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

7-13

1 reference

IgG subclass deficiency in children with recurrent bronchitis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Cell-mediated immune status of children with recurrent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides: follow-up immunization with pneumococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Characterization of the antibody response to a Haemophilus influenzae type b conjugate vaccine in children with recurrent lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Immediate hypersensitivity in adults with IgG deficiency and recurrent respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

IgG Subclass Deficiency and Sinopulmonary Bacterial Infections in Patients With Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Follow-up of pediatric patients with recurrent infection and mild serologic immune abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

The outcome of patients with hypogammaglobulinemia in infancy and early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

OM-85 BV upregulates the expression of adhesion molecules on phagocytes through a CD 14-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Changes in cytokine and nitric oxide secretion by rat alveolar macrophages after oral administration of bacterial extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Selective induction of the glucose-regulated protein grp78 in human monocytes by bacterial extracts (OM-85): a role for calcium as second messenger

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Clinical and immunobiological effects of an orally administered bacterial extract

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Immunoglobulin production in man stimulated by an orally administered bacterial lysate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

IgG subclass levels in infancy and childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Sinusitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Effects of CpG DNA on Th1/Th2 balance in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

Antibody prevalence and immunoglobulin IgG subclass pattern to Norwalk virus in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

IgG subclass deficiency and the day-care generation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979158-7

7 January 2021

10.1016/S0301-0546(03)79158-7

Identifiers

DOI

1 reference

13 September 2017

1 reference